Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_assertion type Assertion NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_head.
- NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_assertion description "[Our results also showed that expressions of glycolytic enzymes pyruvate kinase, glucose-6-phosphate isomerase, fructose-bisphosphate aldolase, lactate dehydrogenase, and phosphoglycerate kinase 1 were down-regulated in drug resistant cells, indicating drug resistance in ovarian cancer is directly associated with a decrease in glycolysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_provenance.
- NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_assertion evidence source_evidence_literature NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_provenance.
- NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_assertion SIO_000772 25096996 NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_provenance.
- NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_assertion wasDerivedFrom befree-2016 NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_provenance.
- NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_assertion wasGeneratedBy ECO_0000203 NP1208108.RAvxTTQS50n-A0zfhri7VJ9HGOdN515l2Di2Sc2xOiMV0130_provenance.